Hillary Syeda
Hillary Syeda is an engineering specialist with AIChE.
ChEnected contributions
SEED Conference Keynote Tom Ellis on the Immense Benefits of Synthetic Biology
Find out what areas of synthetic biology Tom Ellis finds most promising, and hear about what he’ll be discussing in his SEED keynote in June.
Cell-Free Systems in Bioengineering
Hear from six researchers working in the field of cell-free systems to hear about the potential for innovation, advice on entering the field, and more.
Featured Speaker Ashty Karim on Opportunities in Cell-Free Systems
Learn how Ashty got his start in this research area, where he sees great potential for cell-free systems, and what advice he gives to those interested in getting involved in this research.
CRISPR Technologies Speaker Sergey Shmakov on CRISPR-like RNAs
Learn more about Sergey’s upcoming talk and hear what areas he sees as the biggest trends in CRISPR technology.
CRISPR Technologies Speaker Luca Pinello Introduces CRISPRme Tool
The CRISPRme tool enhances the accuracy of off-target predictions by factoring in the individual genetic diversities.
CRISPR Technologies Speaker Max Wilkinson on LINE Mechanisms
Learn about Wilkinson’s work that explores how long interspersed nuclear element (LINE) retrotransposons work, and find out what emerging areas of CRISPR technology he’s watching.
CRISPR Technologies Speaker Matthew Stanton on DNA Delivery Solutions
Matthew Stanton, CSO of Generation Bio, previews what he'll discuss at the conference and also shares thoughts on CRISPR trends and what's on the horizon.
AccBio Conference Keynote Rachel Chikwamba on Developments and Advancements in the Biomanufacturing Industry
Organized by AIChE’s Society for Biological Engineering (SBE), the 8th International Conference on Accelerating Biopharmaceutical Development will be held September 6-8, 2023 in The Royal Sonesta Boston, Cambridge, MA.
AccBio Conference Keynote Ray Deshaies on Making Multispecific Medicines of the Future
Hear from AccBio Conference keynote speaker Raymond Deshaies about the future of biopharmaceutical development.